Bruce & Co. Buys Apple Inc, International Business Machines Corp, Merck Inc, Sells Calpine Corp, Agenus Inc, Astrotech Corp

Investment company Bruce & Co. buys Apple Inc, International Business Machines Corp, Merck Inc, Valeant Pharmaceuticals International Inc, Pfizer Inc, Xtant Medical Holdings Inc, sells Calpine Corp, Agenus Inc, Astrotech Corp during the 3-months ended 2018-03-31, according to the most recent filings of the investment company, Bruce & Co.. As of 2018-03-31, Bruce & Co. owns 37 stocks with a total value of $443 million. These are the details of the buys and sells.

For the details of Robert Bruce's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Robert+Bruce

These are the top 5 holdings of Robert Bruce
  1. Amerco Inc (UHAL) - 185,969 shares, 14.49% of the total portfolio.
  2. NextEra Energy Inc (NEE) - 243,200 shares, 8.97% of the total portfolio.
  3. Allstate Corp (ALL) - 333,800 shares, 7.15% of the total portfolio.
  4. Duke Energy Corp (DUK) - 347,788 shares, 6.08% of the total portfolio.
  5. AbbVie Inc (ABBV) - 271,915 shares, 5.81% of the total portfolio. Shares added by 16.74%
New Purchase: Apple Inc (AAPL)

Bruce & Co. initiated holding in Apple Inc. The purchase prices were between $155.15 and $181.72, with an estimated average price of $172.19. The stock is now traded at around $186.44. The impact to a portfolio due to this purchase was 3.23%. The holding were 85,300 shares as of 2018-03-31.

New Purchase: Xtant Medical Holdings Inc (XTNT)

Bruce & Co. initiated holding in Xtant Medical Holdings Inc. The purchase prices were between $4.62 and $9.75, with an estimated average price of $6.59. The stock is now traded at around $6.44. The impact to a portfolio due to this purchase was 0.53%. The holding were 296,172 shares as of 2018-03-31.

Added: International Business Machines Corp (IBM)

Bruce & Co. added to a holding in International Business Machines Corp by 37.56%. The purchase prices were between $147.59 and $169.12, with an estimated average price of $158.26. The stock is now traded at around $143.74. The impact to a portfolio due to this purchase was 1.39%. The holding were 146,500 shares as of 2018-03-31.

Added: Merck & Co Inc (MRK)

Bruce & Co. added to a holding in Merck & Co Inc by 38.55%. The purchase prices were between $53.41 and $62.07, with an estimated average price of $56.63. The stock is now traded at around $59.20. The impact to a portfolio due to this purchase was 1.23%. The holding were 359,400 shares as of 2018-03-31.

Added: Valeant Pharmaceuticals International Inc (VRX)

Bruce & Co. added to a holding in Valeant Pharmaceuticals International Inc by 42.74%. The purchase prices were between $14.88 and $23.87, with an estimated average price of $18.73. The stock is now traded at around $21.56. The impact to a portfolio due to this purchase was 0.92%. The holding were 855,000 shares as of 2018-03-31.

Added: Pfizer Inc (PFE)

Bruce & Co. added to a holding in Pfizer Inc by 21.96%. The purchase prices were between $33.63 and $39.02, with an estimated average price of $36.23. The stock is now traded at around $35.69. The impact to a portfolio due to this purchase was 0.8%. The holding were 555,332 shares as of 2018-03-31.

Sold Out: Calpine Corp (CPN)

Bruce & Co. sold out a holding in Calpine Corp. The sale prices were between $15.04 and $15.25, with an estimated average price of $15.13.

Sold Out: Agenus Inc (AGEN)

Bruce & Co. sold out a holding in Agenus Inc. The sale prices were between $3.51 and $6.04, with an estimated average price of $4.53.



Here is the complete portfolio of Robert Bruce. Also check out:

1. Robert Bruce's Undervalued Stocks
2. Robert Bruce's Top Growth Companies, and
3. Robert Bruce's High Yield stocks
4. Stocks that Robert Bruce keeps buying